Equity Analysis

Profit & Loss

    Vilin Bio Med Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    78871
    INE0L4V01013
    16.3727599
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    VILINBIO
    163.33
    27.34
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0.12
    10
    0
     
Particulars(INCOME)Mar 2024
( Cr)
Mar 2023
( Cr)
Mar 2022
( Cr)
Mar 2021
( Cr)
Mar 2020
( Cr)
Sales Turnover 15.8012.3111.2111.7216.81
Excise Duty0.000.000.000.000.00
Net Sales15.8012.3111.2111.7216.81
Other Income 0.320.020.000.000.01
Stock Adjustments -0.21-0.080.010.020.20
Total Income15.9112.2511.2211.7417.02
EXPENDITURE :
Raw Materials 12.807.108.889.0613.92
Power & Fuel Cost0.000.000.000.200.22
Employee Cost 0.800.780.850.911.20
Other Manufacturing Expenses 0.020.090.330.130.10
Selling & Administrative Expenses 0.361.330.400.610.61
Miscellaneous Expenses 0.800.370.00-0.020.06
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.00
Total Expenditure14.789.6710.4610.8816.11
Operating Profit1.152.600.770.860.92
Interest 0.790.650.510.440.41
Gross Profit0.361.950.260.420.51
Depreciation0.130.170.220.260.31
Profit Before Tax0.231.780.040.160.20
Tax0.050.530.010.040.04
Fringe Benefit tax0.000.000.000.000.00
Deferred Tax0.010.010.000.000.00
Reported Net Profit0.161.250.030.120.16
Extraordinary Items 0.000.000.000.000.00
Adjusted Net Profit0.161.250.030.120.16
Adjustment below Net Profit 0.00-4.610.000.000.00
P & L Balance brought forward0.503.873.843.723.55
Statutory Appropriations0.000.000.000.000.00
Appropriations 0.000.000.000.000.00
P & L Balance carried down0.660.503.873.843.72
Dividend0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Equity Dividend %0.000.000.000.000.00
Dividend Per Share(Rs)0.000.000.000.000.00
Earnings Per Share-Unit Curr0.121.250.100.370.49
Earnings Per Share(Adj)-Unit Curr0.121.250.100.370.49
Book Value-Unit Curr16.3710.7322.4122.3121.94
Book Value(Adj)-Unit Curr16.3710.7322.4122.3121.94